Status:
COMPLETED
Patient Education for Patients With Irritable Bowel Syndrome (IBS)
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Patient Education
IBS - Irritable Bowel Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this randomized controlled study in patients with irritable bowel syndrome (IBS) the investigators plan to compare the effects of a structured patient group education (IBS School) with structured e...
Detailed Description
In this randomized controlled study in patients with irritable bowel syndrome (IBS) the investigators plan to compare the effects of a structured patient group education (IBS School), which previously...
Eligibility Criteria
Inclusion
- IBS according to the Rome III criteria
Exclusion
- organic GI disease and/or another disease potentially affecting the GI symptoms
- severe psychiatric disease due to potential problems to participate in a group intervention
- disability to communicate in the Swedish language
- disability to use a computer or not have access to a computer or internet
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03466281
Start Date
August 1 2016
End Date
November 20 2017
Last Update
March 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Internal Medicine, Sahlgrenska University Hospital
Gothenburg, Sweden, S413-45